Page last updated: 2024-08-18

isomethyleugenol and Leukemia, Myelomonocytic, Chronic

isomethyleugenol has been researched along with Leukemia, Myelomonocytic, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akdag, R; Mufti, GJ; Ozbek, N; Stephenson, J1
Orkin, SH; Skalnik, DG; Strauss, EC1

Other Studies

2 other study(ies) available for isomethyleugenol and Leukemia, Myelomonocytic, Chronic

ArticleYear
Methylation status within exon 3 of the c-myc gene as a prognostic marker in myeloma and leukaemia.
    Leukemia research, 1993, Volume: 17, Issue:3

    Topics: Acute Disease; Biomarkers, Tumor; Bone Marrow; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA, Neoplasm; Exons; Genes, myc; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Methylation; Multiple Myeloma; Prognosis

1993
CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.
    The Journal of biological chemistry, 1991, Sep-05, Volume: 266, Issue:25

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; CCAAT-Enhancer-Binding Proteins; Cloning, Molecular; Cytochrome b Group; Deoxyribonuclease I; DNA; DNA-Binding Proteins; Gene Expression Regulation; Humans; Leukemia, Myelomonocytic, Chronic; Methylation; Molecular Sequence Data; Phagocytes; Promoter Regions, Genetic; Repressor Proteins; Sea Urchins; Tumor Cells, Cultured

1991